LYRA Shares Outstanding History



Below is a table of the LYRA shares outstanding history going back to 5/1/2020:

Date LYRA Shares Outstanding
5/1/202012.38M
7/31/202012.92M
11/2/202012.93M
3/1/202112.95M
5/3/202113.00M
8/2/202113.00M
11/1/202113.00M
3/1/202213.01M
5/1/202231.83M
8/1/202231.83M
11/1/202231.83M
3/1/202331.83M
5/1/202331.84M
8/1/202349.55M
11/1/202352.56M
3/1/202459.74M
4/15/202460.96M
8/1/202465.46M
11/1/202465.46M

Also see: LYRA Market Cap History
LYRA YTD Return
LYRA Historical Shares Outstanding:
+44.71% CAGR
LYRA Historical Shares Outstanding: +44.71% CAGR

Mouse over chart for data details
5/1/2020 ...11/1/2024
Lyra Therapeutics, Inc. is a clinical-stage biotechnology company. Co. is focused on the development and commercialization of therapies for the localized treatment of patients with chronic rhinosinusitis (CRS). Co. has two investigational product candidates, LYR-210 and LYR-220, in late-stage development for CRS, a prevalent inflammatory disease of the paranasal sinuses that leads to debilitating symptoms and significant morbidities. LYR-210 and LYR-220 are bioresorbable nasal implants designed to be administered in a brief, in-office procedure and are intended to deliver six months of continuous mometasone furoate drug therapy to the sinonasal passages. We show 19 historical shares outstanding datapoints in our coverage of LYRA's shares outstanding history.

Understanding the changing numbers of LYRA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LYRA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LYRA by allowing them to research LYRA shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree LYRA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Lyra Therapeutics (LYRA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

MACK Shares Outstanding History
MASI Shares Outstanding History
MBIO Shares Outstanding History
MBOT Shares Outstanding History
MBRX Shares Outstanding History
MBVX Shares Outstanding History
MCK Shares Outstanding History
MCRB Shares Outstanding History
MD Shares Outstanding History
MDCO Shares Outstanding History
More Healthcare companies »

 

LYRA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2025, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.